Abata Therapeutics

Company profile

Abata Therapeutics company profile

Abata Therapeutics is focused on translating the biology of regulatory t cells into transformational medicines for patients living with progressive multiple sclerosis and other severe autoimmune and inflammatory diseases. Abata leverages regulatory T cells (Tregs) to create therapies that aim to restore immune system balance in patients with autoimmune conditions. The company's approach involves engineering Tregs to specifically target disease-related antigens, allowing for precise and effective treatment of diseases like multiple sclerosis (MS) and type 1 diabetes. Abata Therapeutics was founded by industry experts with deep experience in immunology and cell therapy, and it has received significant investment from venture..... For more information, log in to dureach.com to view the full company profile.